• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.82% Nasdaq Up 2.46%

    NeurogesX, Inc. (NGSX)

    -Other OTC
    0.00 0.00(0.00%) 10:16AM EDT
    |After Hours : 0.28 0.00 (0.00%) 4:13PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.00
    Open:0.00
    Bid:N/A
    Ask:N/A
    1y Target Est:1.00
    Beta:-8.44778
    Next Earnings Date:N/A
    Day's Range:0.00 - 0.00
    52wk Range:0.00 - 0.02
    Volume:20,000
    Avg Vol (3m):9,999
    Market Cap:143.33K
    P/E (ttm):N/A
    EPS (ttm):-0.96
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for NGSX at this time.

    Comparison

    Symbol% ChgMkt Cap
    NGSX 0.00%143.33K
    LLYUp 2.52%86.64B
    ENDPUp 2.01%15.61B
    PFEUp 1.95%197.17B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):0.01
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    NeurogesX, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel non-opioid, pain management therapies to address unmet medical needs. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback